Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : Effect of dipeptidyl peptidase-4 inhibitors on postprandial glucagon level in patients with type 2 diabetes mellitus: A systemic review and meta-analysis - Chai_2022_Front.Endocrinol.(Lausanne)_13_994944 |
| Author(s) : Chai S , Zhang R , Zhang Y , Carr RD , Zheng Y , Rajpathak S , Ji L |
| Ref : Front Endocrinol (Lausanne) , 13 :994944 , 2022 |
| Abstract : Chai_2022_Front.Endocrinol.(Lausanne)_13_994944 |
| ESTHER : Chai_2022_Front.Endocrinol.(Lausanne)_13_994944 |
| PubMedSearch : Chai_2022_Front.Endocrinol.(Lausanne)_13_994944 |
| PubMedID: 36313782 |
| Title : A comparative study of the binding properties, dipeptidyl peptidase-4 (DPP-4) inhibitory activity and glucose-lowering efficacy of the DPP-4 inhibitors alogliptin, linagliptin, saxagliptin, sitagliptin and vildagliptin in mice - Berger_2018_Endocrinol.Diabetes.Metab_1_e00002 |
| Author(s) : Berger JP , SinhaRoy R , Pocai A , Kelly TM , Scapin G , Gao YD , Pryor KAD , Wu JK , Eiermann GJ , Xu SS , Zhang X , Tatosian DA , Weber AE , Thornberry NA , Carr RD |
| Ref : Endocrinol Diabetes Metab , 1 :e00002 , 2018 |
| Abstract : Berger_2018_Endocrinol.Diabetes.Metab_1_e00002 |
| ESTHER : Berger_2018_Endocrinol.Diabetes.Metab_1_e00002 |
| PubMedSearch : Berger_2018_Endocrinol.Diabetes.Metab_1_e00002 |
| PubMedID: 30815539 |
| Gene_locus related to this paper: human-DPP4 |
| Title : Secretion and dipeptidyl peptidase-4-mediated metabolism of incretin hormones after a mixed meal or glucose ingestion in obese compared to lean, nondiabetic men - Carr_2010_J.Clin.Endocrinol.Metab_95_872 |
| Author(s) : Carr RD , Larsen MO , Jelic K , Lindgren O , Vikman J , Holst JJ , Deacon CF , Ahren B |
| Ref : J Clinical Endocrinology Metab , 95 :872 , 2010 |
| Abstract : Carr_2010_J.Clin.Endocrinol.Metab_95_872 |
| ESTHER : Carr_2010_J.Clin.Endocrinol.Metab_95_872 |
| PubMedSearch : Carr_2010_J.Clin.Endocrinol.Metab_95_872 |
| PubMedID: 20008019 |
| Title : DPP-4 inhibitor therapy: new directions in the treatment of type 2 diabetes - Deacon_2008_Front.Biosci_13_1780 |
| Author(s) : Deacon CF , Carr RD , Holst JJ |
| Ref : Front Biosci , 13 :1780 , 2008 |
| Abstract : Deacon_2008_Front.Biosci_13_1780 |
| ESTHER : Deacon_2008_Front.Biosci_13_1780 |
| PubMedSearch : Deacon_2008_Front.Biosci_13_1780 |
| PubMedID: 17981667 |
| Title : Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake - Ryskjaer_2006_Eur.J.Endocrinol_155_485 |
| Author(s) : Ryskjaer J , Deacon CF , Carr RD , Krarup T , Madsbad S , Holst J , Vilsboll T |
| Ref : European Journal of Endocrinology , 155 :485 , 2006 |
| Abstract : Ryskjaer_2006_Eur.J.Endocrinol_155_485 |
| ESTHER : Ryskjaer_2006_Eur.J.Endocrinol_155_485 |
| PubMedSearch : Ryskjaer_2006_Eur.J.Endocrinol_155_485 |
| PubMedID: 16914604 |
| Title : Neutral endopeptidase 24.11 and dipeptidyl peptidase IV are both mediators of the degradation of glucagon-like peptide 1 in the anaesthetised pig - Plamboeck_2005_Diabetologia_48_1882 |
| Author(s) : Plamboeck A , Holst JJ , Carr RD , Deacon CF |
| Ref : Diabetologia , 48 :1882 , 2005 |
| Abstract : Plamboeck_2005_Diabetologia_48_1882 |
| ESTHER : Plamboeck_2005_Diabetologia_48_1882 |
| PubMedSearch : Plamboeck_2005_Diabetologia_48_1882 |
| PubMedID: 16025254 |